Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cytidine-5'-monophosphate-5-n-acetylneuraminic acid
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
Cytidine-5'-monophosphate-5-N-acetylneuraminic acid (CMP-NeuNAc) is a nucleotide sugar and the activated form of sialic acid (N-acetylneuraminic acid). It serves as a donor substrate for sialyltransferases in the enzymatic sialylation of glycans and glycoproteins. This molecule is essential for the biosynthesis of sialoglycoconjugates in both prokaryotic and eukaryotic cells. In humans and other organisms, it is synthesized by the enzyme N-acylneuraminate cytidylyltransferase (CMAS), which catalyzes the activation of NeuNAc to form CMP-NeuNAc—a critical step for cell surface expression of sialic acids. These modifications are important for cell-cell interactions and pathogen recognition[1][2][3]. The compound is primarily used as an experimental biochemical reagent rather than a therapeutic pharmaceutical.
- Other names
- cytidine monophosphate N-acetylneuraminic acidacetylneuraminic acid CMPcytidine-5′-monophospho-N-acetylneuraminic acidcytidine monophosphate N-acetylneuraminateCMP-D-N-acetylneuraminic acid
02
Targets
ST (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4)
Beyond the preview
Go deeper on cytidine-5'-monophosphate-5-n-acetylneuraminic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cytidine-5'-monophosphate-5-n-acetylneuraminic acid.